
Stephen L. Rawlings
Examiner (ID: 18470, Phone: (571)272-0836 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1642, 1643, 1646 |
| Total Applications | 1483 |
| Issued Applications | 633 |
| Pending Applications | 153 |
| Abandoned Applications | 701 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7527032
[patent_doc_number] => 08043623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-25
[patent_title] => 'Immunogenic peptides for the treatment of prostate and breast cancer'
[patent_app_type] => utility
[patent_app_number] => 12/430837
[patent_app_country] => US
[patent_app_date] => 2009-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 18
[patent_no_of_words] => 22855
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/043/08043623.pdf
[firstpage_image] =>[orig_patent_app_number] => 12430837
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/430837 | Immunogenic peptides for the treatment of prostate and breast cancer | Apr 26, 2009 | Issued |
Array
(
[id] => 6161551
[patent_doc_number] => 20110159569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'ANTI-NUCLEIC ACID ANTIBODY INDUCING CELL DEATH OF CANCER CELLS AND COMPOSITION FOR PREVENTING OR TREATING CANCERS COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/990405
[patent_app_country] => US
[patent_app_date] => 2009-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 15044
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20110159569.pdf
[firstpage_image] =>[orig_patent_app_number] => 12990405
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/990405 | ANTI-NUCLEIC ACID ANTIBODY INDUCING CELL DEATH OF CANCER CELLS AND COMPOSITION FOR PREVENTING OR TREATING CANCERS COMPRISING THE SAME | Apr 15, 2009 | Abandoned |
| 12/422975 | INHIBITION OF METASTASIS BY CELL PENETRATING PEPTIDES | Apr 12, 2009 | Abandoned |
Array
(
[id] => 8375472
[patent_doc_number] => 08258261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Induction of tumor immunity by variants of folate binding protein'
[patent_app_type] => utility
[patent_app_number] => 12/422600
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 65797
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12422600
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/422600 | Induction of tumor immunity by variants of folate binding protein | Apr 12, 2009 | Issued |
Array
(
[id] => 8398188
[patent_doc_number] => 08268568
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'Methods and compositions for categorizing patients'
[patent_app_type] => utility
[patent_app_number] => 12/386176
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 68
[patent_no_of_words] => 21396
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12386176
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/386176 | Methods and compositions for categorizing patients | Apr 12, 2009 | Issued |
Array
(
[id] => 7650862
[patent_doc_number] => 20110300131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'DETECTION AND TREATMENT OF PANCREATIC, OVARIAN AND OTHER CANCERS'
[patent_app_type] => utility
[patent_app_number] => 12/937190
[patent_app_country] => US
[patent_app_date] => 2009-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18020
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20110300131.pdf
[firstpage_image] =>[orig_patent_app_number] => 12937190
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/937190 | Detection and treatment of pancreatic, ovarian and other cancers | Apr 9, 2009 | Issued |
Array
(
[id] => 5557776
[patent_doc_number] => 20090269353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'Stimulation of T Cells Against Self-Antigens Using CTLA-4 Blocking Agents'
[patent_app_type] => utility
[patent_app_number] => 12/421560
[patent_app_country] => US
[patent_app_date] => 2009-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 22867
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20090269353.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421560
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421560 | Stimulation of T Cells Against Self-Antigens Using CTLA-4 Blocking Agents | Apr 8, 2009 | Abandoned |
Array
(
[id] => 5385690
[patent_doc_number] => 20090226935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'NUCLEAR MATRIX PROTEIN ALTERATIONS ASSOCIATED WITH COLON CANCER AND COLON METASTASIS TO THE LIVER, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/419654
[patent_app_country] => US
[patent_app_date] => 2009-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12731
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226935.pdf
[firstpage_image] =>[orig_patent_app_number] => 12419654
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/419654 | NUCLEAR MATRIX PROTEIN ALTERATIONS ASSOCIATED WITH COLON CANCER AND COLON METASTASIS TO THE LIVER, AND USES THEREOF | Apr 6, 2009 | Abandoned |
Array
(
[id] => 6148749
[patent_doc_number] => 20110020344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR CD22'
[patent_app_type] => utility
[patent_app_number] => 12/934214
[patent_app_country] => US
[patent_app_date] => 2009-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 23211
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020344.pdf
[firstpage_image] =>[orig_patent_app_number] => 12934214
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/934214 | Human monoclonal antibodies specific for CD22 | Mar 31, 2009 | Issued |
Array
(
[id] => 8198216
[patent_doc_number] => 20120122128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS'
[patent_app_type] => utility
[patent_app_number] => 12/403531
[patent_app_country] => US
[patent_app_date] => 2009-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 60658
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122128.pdf
[firstpage_image] =>[orig_patent_app_number] => 12403531
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/403531 | Immuno-based botulinum toxin serotype A activity assays | Mar 12, 2009 | Issued |
| 12/299218 | NOVEL AGENTS AND USE THEREOF | Mar 11, 2009 | Abandoned |
Array
(
[id] => 5342756
[patent_doc_number] => 20090181406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'KITS FOR DETECTING CERVICAL DYSPLASIA'
[patent_app_type] => utility
[patent_app_number] => 12/400629
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16634
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181406.pdf
[firstpage_image] =>[orig_patent_app_number] => 12400629
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/400629 | KITS FOR DETECTING CERVICAL DYSPLASIA | Mar 8, 2009 | Abandoned |
Array
(
[id] => 8642370
[patent_doc_number] => 08367353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-05
[patent_title] => 'Method for improved diagnosis of dysplasias'
[patent_app_type] => utility
[patent_app_number] => 12/381098
[patent_app_country] => US
[patent_app_date] => 2009-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12134
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12381098
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/381098 | Method for improved diagnosis of dysplasias | Mar 5, 2009 | Issued |
Array
(
[id] => 5403519
[patent_doc_number] => 20090238833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 12/395575
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 30376
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20090238833.pdf
[firstpage_image] =>[orig_patent_app_number] => 12395575
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/395575 | PROTEIN | Feb 26, 2009 | Abandoned |
Array
(
[id] => 5403520
[patent_doc_number] => 20090238834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'IDENTIFICATION OF PROTEIN ASSOCIATED WITH HEPATOCELLULAR CARCINOMA, GLIOBLASTOMA AND LUNG CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/395579
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32599
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20090238834.pdf
[firstpage_image] =>[orig_patent_app_number] => 12395579
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/395579 | IDENTIFICATION OF PROTEIN ASSOCIATED WITH HEPATOCELLULAR CARCINOMA, GLIOBLASTOMA AND LUNG CANCER | Feb 26, 2009 | Abandoned |
Array
(
[id] => 6038437
[patent_doc_number] => 20110091486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'INHIBITION OF POST-RADIATION TUMOR GROWTH'
[patent_app_type] => utility
[patent_app_number] => 12/919654
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13743
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091486.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919654
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919654 | INHIBITION OF POST-RADIATION TUMOR GROWTH | Feb 26, 2009 | Abandoned |
Array
(
[id] => 5385202
[patent_doc_number] => 20090226447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/378993
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 41672
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226447.pdf
[firstpage_image] =>[orig_patent_app_number] => 12378993
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/378993 | Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof | Feb 18, 2009 | Issued |
Array
(
[id] => 6223883
[patent_doc_number] => 20100056762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'SPECIFIC BINDING PROTEINS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/388504
[patent_app_country] => US
[patent_app_date] => 2009-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 155
[patent_figures_cnt] => 155
[patent_no_of_words] => 78395
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 62
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12388504
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/388504 | SPECIFIC BINDING PROTEINS AND USES THEREOF | Feb 17, 2009 | Abandoned |
Array
(
[id] => 5315522
[patent_doc_number] => 20090280120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'METHODS OF TREATING PROSTATE CANCER WITH ANTI-PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 12/371399
[patent_app_country] => US
[patent_app_date] => 2009-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 83628
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280120.pdf
[firstpage_image] =>[orig_patent_app_number] => 12371399
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/371399 | METHODS OF TREATING PROSTATE CANCER WITH ANTI-PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODIES | Feb 12, 2009 | Abandoned |
Array
(
[id] => 6007060
[patent_doc_number] => 20110059091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'INHIBITORS OF ONCOGENIC ISOFORMS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/866013
[patent_app_country] => US
[patent_app_date] => 2009-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 50630
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059091.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866013
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866013 | INHIBITORS OF ONCOGENIC ISOFORMS AND USES THEREOF | Feb 3, 2009 | Abandoned |